These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 33307532)
1. Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT. Stögbauer L; Thomas C; Wagner A; Warneke N; Bunk EC; Grauer O; Canisius J; Paulus W; Stummer W; Senner V; Brokinkel B J Neurosurg; 2021 Sep; 135(3):845-854. PubMed ID: 33307532 [TBL] [Abstract][Full Text] [Related]
2. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review. Stögbauer L; Stummer W; Senner V; Brokinkel B Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677 [TBL] [Abstract][Full Text] [Related]
3. hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas. Fürtjes G; Köchling M; Peetz-Dienhart S; Wagner A; Heß K; Hasselblatt M; Senner V; Stummer W; Paulus W; Brokinkel B J Neurooncol; 2016 Oct; 130(1):79-87. PubMed ID: 27465278 [TBL] [Abstract][Full Text] [Related]
4. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Guilleret I; Benhattar J Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633 [TBL] [Abstract][Full Text] [Related]
5. Expression of decitabine-targeted oncogenes in meningiomas in vivo. Canisius J; Wagner A; Bunk EC; Spille DC; Stögbauer L; Grauer O; Hess K; Thomas C; Paulus W; Stummer W; Senner V; Brokinkel B Neurosurg Rev; 2022 Aug; 45(4):2767-2775. PubMed ID: 35445910 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. Tao SF; Zhang CS; Guo XL; Xu Y; Zhang SS; Song JR; Li R; Wu MC; Wei LX World J Gastroenterol; 2012 May; 18(19):2334-43. PubMed ID: 22654424 [TBL] [Abstract][Full Text] [Related]
7. Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma. Nakano T; Fujimoto K; Tomiyama A; Takahashi M; Achiha T; Arita H; Kawauchi D; Yasukawa M; Masutomi K; Kondo A; Narita Y; Maehara T; Ichimura K Cancer Sci; 2022 Feb; 113(2):697-708. PubMed ID: 34839570 [TBL] [Abstract][Full Text] [Related]
8. TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Spiegl-Kreinecker S; Lötsch D; Neumayer K; Kastler L; Gojo J; Pirker C; Pichler J; Weis S; Kumar R; Webersinke G; Gruber A; Berger W Neuro Oncol; 2018 Nov; 20(12):1584-1593. PubMed ID: 30010853 [TBL] [Abstract][Full Text] [Related]
9. Molecular predictors for decitabine efficacy in meningiomas - a pilot study. Spille DC; Thomas C; Wagner A; Grauer OM; Canisius J; Bunk EC; Stummer W; Eich HT; Paulus W; Senner V; Brokinkel B J Neurooncol; 2023 Aug; 164(1):97-105. PubMed ID: 37477823 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma. Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234 [TBL] [Abstract][Full Text] [Related]
11. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004 [TBL] [Abstract][Full Text] [Related]
12. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death. Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Devereux TR; Horikawa I; Anna CH; Annab LA; Afshari CA; Barrett JC Cancer Res; 1999 Dec; 59(24):6087-90. PubMed ID: 10626795 [TBL] [Abstract][Full Text] [Related]
14. TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer. Li S; Hu G; Chen Y; Sang Y; Tang Q; Liu R Cancer Cell Int; 2024 Aug; 24(1):271. PubMed ID: 39097722 [TBL] [Abstract][Full Text] [Related]
15. The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation. Guilleret I; Yan P; Guillou L; Braunschweig R; Coindre JM; Benhattar J Carcinogenesis; 2002 Dec; 23(12):2025-30. PubMed ID: 12507925 [TBL] [Abstract][Full Text] [Related]
16. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines. Zhang ZX; Wang Y; Tao ZZ; Chen SM; Xiao BK; Zhou T Cancer Biother Radiopharm; 2014 Sep; 29(7):289-94. PubMed ID: 25153197 [TBL] [Abstract][Full Text] [Related]
17. DNA demethylation with 5-aza-2'-deoxycytidine induces the senescence-associated secretory phenotype in the immortal fish cell line, EPC. Futami K; Maita M; Katagiri T Gene; 2019 May; 697():194-200. PubMed ID: 30802536 [TBL] [Abstract][Full Text] [Related]
18. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors. Chen X; Liu L; Mims J; Punska EC; Williams KE; Zhao W; Arcaro KF; Tsang AW; Zhou X; Furdui CM Epigenetics; 2015; 10(6):545-61. PubMed ID: 25961636 [TBL] [Abstract][Full Text] [Related]
19. Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. Nomoto K; Maekawa M; Sugano K; Ushiama M; Fukayama N; Fujita S; Kakizoe T Jpn J Clin Oncol; 2002 Jan; 32(1):3-8. PubMed ID: 11932355 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Püttmann S; Senner V; Braune S; Hillmann B; Exeler R; Rickert CH; Paulus W Lab Invest; 2005 Sep; 85(9):1163-71. PubMed ID: 15965488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]